J Dent Anesth Pain Med.
2020 Apr;20(2):63-72. 10.17245/jdapm.2020.20.2.63.
Narrative review: the evidence for neurotoxicity ofdental local anesthetics
- Affiliations
-
- 1Division of Oral Diagnostics and Surgical Sciences, University of Western Australia, Perth, Australia
- 2University of Washington, Seattle, USA
- KMID: 2500089
- DOI: http://doi.org/10.17245/jdapm.2020.20.2.63
Abstract
- Dental local anesthesia is performed daily on a global scale. Adverse effects are rare, but the topic of neurotoxicity of local anesthetics deserves to be explored, as publications can be controversial and confusing. Therefore, a need was felt to address and question the evidence for potential neurotoxicity of dental local anesthetics. This review aimed to assess the studies published on the neurotoxicity of dental local anesthetics. A PubmedⓇ search was conducted between January 2019 and August 2019. This revealed 2802 hits on the topic of neurotoxicity or cytotoxicity of the following anesthetics: lidocaine, prilocaine, mepivacaine, articaine, ropivacaine, and bupivacaine. Only 23 papers were deemed eligible for this review: 17 in vitro studies, 3 reviews and 3 audits of national inquiries. The heterogeneous literature on this topic showed that all dental local anesthetics are potentially neurotoxic in a concentration and/or exposure time fashion. There seems no consensus about what cell lines are to be used to investigate the neurotoxicity of local anesthetics, which makes the comparison between studies difficult and ambiguous. However, the bottom line is that all dental local anesthetics have a neurotoxic potential, but that there is no unanimity in the publications about which local anesthetic is the least or the most neurotoxic.
